Introduction
============

The application of nanotechnology in industry is quickly growing, with a worldwide market size estimated to be in excess of US\$1 trillion by the year 2015.[@b1-ijn-9-1379] Despite the rapid progress and early acceptance of nanotechnology, the potential for adverse health effects in humans and the environment has not yet been established. Although several research groups have demonstrated that exposure to nanoparticles (NPs) may affect cellular viability and growth, little is known regarding the potential mechanism(s) of toxicity.[@b2-ijn-9-1379]--[@b4-ijn-9-1379] It is thought that nanoparticles can disrupt and impair normal cellular function through a number of mechanisms.[@b5-ijn-9-1379] For example, nanoparticles may contain toxic materials or ions that directly or indirectly harm the cell through the generation of reactive oxygen species (ROS). Indeed, cytotoxicity due to ROS generation has been reported with a number of different nanoparticles, including titanium dioxide (TiO~2~),[@b6-ijn-9-1379] C60 fullerenes,[@b7-ijn-9-1379] and CeO~2~.[@b8-ijn-9-1379] Independent of composition, nanoparticles may also cause cellular damage due to their ability to adhere to or to pass through cell membranes.[@b5-ijn-9-1379],[@b9-ijn-9-1379]

Yttrium oxide nanoparticles (Y~2~O~3~ NPs) are used in a number of different applications, including biological imaging, the material sciences, and in the chemical synthesis of inorganic compounds.[@b10-ijn-9-1379] The Y~2~O~3~ NPs are thought to be one of the most important yttrium compounds and are widely used in the manufacturing of plasma televisions, cathode ray display panles and in microwave filters. Other applications for Y~2~O~3~ NPs include use in high-temperature/infrared-shielding applications and as additives in paint, plastic, steel, iron, and optics.[@b11-ijn-9-1379] As Y~2~O~3~ NPs use accelerates, the risk of intentional and inadvertent release into the environment increases, with possible implications for human and environmental health.

How exposure to the Y~2~O~3~ NPs may affect physiological systems is not yet known. Given the delicate structure of the kidney filtration system, along with the major role that this organ plays in the filtration of bodily fluids and the excretion of waste products, it is quite possible that an inappropriate exposure to Y~2~O~3~ NPs may affect renal cell structure and function. To investigate this possibility, the well-characterized human embryonic kidney (HEK293) cell line was chosen as a test system, given the widespread use of these cells to evaluate the cytotoxic effects of chemicals.[@b12-ijn-9-1379] Other, more recent reports demonstrate the use of these cells for investigating the potential toxicity of nanoparticles.[@b13-ijn-9-1379]--[@b16-ijn-9-1379]

Andelman et al examined the effects of exposure to different types of Y~2~O~3~ NPs on human foreskin fibroblast cells and demonstrated a concentration-dependent (25--500 μg/mL) cytotoxicity by live/dead cell assay.[@b10-ijn-9-1379] To investigate the potential mechanisms of the Y~2~O~3~ NPs toxicity, we exposed the HEK293 cells to different concentrations of NPs to first determine the acute cytotoxic dose (IC~50~). Once determined, this information was then used as a starting point for investigating the potential mechanisms of cytotoxicity, using a variety of different approaches. To increase the applicability of our findings to those who may not be well-versed in nanotechnology, the inclusion of paraquat, a widely known toxicant, was often included in an attempt to allow meaningful comparisons between the fields of nanotoxicology and traditional toxicology. Taken together, our data suggest that an exposure to the Y~2~O~3~ NPs is associated with increased cytotoxicity and genotoxicity. Additional studies to confirm these findings using other types of Y~2~O~3~ NPs, cell types, and experimental designs may be warranted.

Materials and methods
=====================

Materials
---------

Y~2~O~3~ NPs (99.95% purity as determined by inductively coupled plasma mass spectrometry, were purchased from the MK Impex Corporation (Mississauga, ON, Canada). The JC-1 Mitochondrial Membrane Potential Detection Kit was purchased from Cell Technology, Inc (Mountain View, CA, USA); the OxiSelect™ ROS Assay Kit was from Cell Biolabs, Inc., (San Diego, CA, USA); the Comet Assay™ kit was from Trevigen, Inc., (Gaithersburg, MD, USA). The Annexin V-FITC/PI Kit System was purchased from BD Biosciences (San Jose, CA, USA); the Lactate Dehydrogenase (LDH) Activity Assay Kit was from BioVision Inc., (Milpitas, California, USA). The Lonza PAGEr™ Gold Precast Gels were from (Lonza Group Ltd, Basel, Switzerland) and the Amersham ECL Western Blotting Detection Reagent and membranes were from GE Healthcare Bio-Sciences Corporation (Piscataway, NJ, USA).

All primary and secondary antibodies, positive control proteins, biotinylated ladder, and the antibiotin horseradish peroxidase antibody were from Cell Signaling Technology, Inc., (Danvers, MA, USA). The prestained sodium dodecyl sulfate polyacrylamide gel electrophoresis standards were from Bio-Rad Life Science (Hercules, CA, USA). The tissue culture media was from American Type Culture Collection (Manassas, VA, USA), fetal bovine serum was from Atlanta Biological Inc., (Flowery Branch, GA, USA); and the Bradford reagent was from Bio-Rad Life Science. All other tissue culture reagents, chemicals, and products were purchased from BD (Franklin Lakes, NJ, USA) or Sigma-Aldrich (St Louis, MO, USA).

Aqueous Y~2~O~3~ NPs preparation and atomic force microscopy
------------------------------------------------------------

The Y~2~O~3~ NPs stock suspensions (2.5 mg/mL) were prepared in double distilled water by sonication, using a Vibra-Cell Sonicator (Sonics and Materials, Inc., Newtown, CT, USA) at 600 watts for 5 minutes at room temperature. Particles were imaged in their native state using a MultiMode-8 Atomic Force Microscope (Bruker AXS Inc., Ewing Township, NJ, USA) in the tapping mode. Briefly, a few drops of Y~2~O~3~ NPs were placed on freshly peeled mica substrate and allowed to dry in a Petri dish floating in a sonicator water bath (VWR, Radnor, PA, USA) for 30 minutes at 240 watts. Images were recorded using the contact mode. At least 100 particles were analyzed for each of the different stock suspensions.

Transmission electron microscopy
--------------------------------

Particles were imaged in their native state using a Hitachi H-7000 TEM electron microscope at 75 keV and a magnification of 50,000× (Hitachi Ltd, Tokyo, Japan). ImageJ software (National Institutes of Health, Bethesda, MD, USA) was used to calculate particle size from at least 100 NPs.

Dynamic light scattering
------------------------

The hydrodynamic size and size distribution of the Y~2~O~3~ NPs were evaluated in Milli-Q water (Millipore, Bedford, MA, USA) using back-scattered light with a particle size analyzer (Model-LB-550, HORIBA Ltd, Kyoto, Japan) that was equipped with a heliumneon laser (633 nm). Experiments were performed in triplicate with freshly prepared samples over three different occasions.

X-ray diffraction analysis
--------------------------

Dried Y~2~O~3~ NPs were placed on a glass slide with a thin layer of vacuum grease. The X-ray diffraction (XRD) spectra were taken using a Scintag XDS2000 powder XRD instrument, using a scale range of 20--69.98° for 20 theta (Θ), a step size of 0.03° and a dwell time of 2.250 seconds. The powder diffraction file JCPDF Number 41-1105 was taken from the reference libraries of the International Center for Diffraction Data®.

Cell culture and toxicity studies
---------------------------------

The HEK293 cells (CRL-1573TM, American Type Culture Collection) were grown in 25 cm^2^ cell culture flasks at 30°C with 5% CO~2~ in Dulbecco's Modified Eagle's Medium high glucose medium containing 1% penicillin/streptomycin (10,000 U penicillin and 10 mg streptomycin/mL) and supplemented with 5% of fetal bovine serum. The stock solutions of Y~2~O~3~ NPs were serially diluted in sterile water to different concentrations. These were sonicated (600 watts ×2 minutes at 22°C--23°C) and then added to the growth media. The IC~50~ dose dependent of Y~2~O~3~ NPs was determined using the 3-\[4,5-dimethylthiazol-2-yl\]-2,5 diphenyl tetrazolium bromide (MTT) assay, as detailed previously.[@b17-ijn-9-1379]

Observation of morphological alterations, cell proliferation, and lactate dehydrogenase leakage
-----------------------------------------------------------------------------------------------

The HEK293 cells (1 × 10^5^/mL) were grown in 24-, 12-, or 6-well tissue culture plates until 70%--80% confluence, the media removed, and then incubated with fresh media containing different Concentrations of Y~2~O~3~ NPs (0, 0.25, 6.125, 12.26, 25, or 50 μg/mL) for 10 hours, 24 hours, or 48 hours. Cell morphology was observed using an AXiovert40c/CFL inverted microscope (Carl zeiss microimaging, Inc, One zeiss drive, Thornwood, NY, USA). Cell survival was assessed using the MTT assay,[@b17-ijn-9-1379] while the lactate dehydrogenase (LDH) release was measured by enzyme-linked immunosorbent assay using a LDH assay kit (BioVision), as detailed by the manufacturer. Cell survival and LDH leakage were determined in triplicate in independent experiments using 6 wells per concentration.

Induction of apoptosis and necrosis by Y~2~O~3~ nanoparticles
-------------------------------------------------------------

The degree of cellular apoptosis and necrosis was assessed using annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI), staining as outlined previously.[@b18-ijn-9-1379] Briefly, treated cells were harvested by trypsin, labeled with annexin V-FITC and PI (BD Biosciences), and subjected to flow cytometry (FACSCalibur™, BD Biosciences). At least, 10,000 cells were analyzed from each sample for annexin V+/PI−, annexin V+/PI+, and annexin V−/PI+ reactivity.

Western blotting
----------------

Cells were washed with cold phosphate buffered saline (PBS), collected by trypsinization, and centrifuged at 400× *g* for 10 minutes. After lysis using the CelLytic M Cell Lysis Reagent (Sigma-Aldrich), the supernatant was collected and the protein content was estimated in triplicate using the Bradford reagent with bovine serum albumin as a standard. Fifty μg of total protein per well was then subjected to electrophoresis and transferred to Hybond-C nitrocellulose membranes (Amersham™ Hybond, GE Healthcare Bio-Sciences Corporation) using standard conditions. Membranes were incubated overnight at 4°C with the appropriate primary antibody, washed extensively, and then incubated [f]{.ul}or 1 hour at room temperature with a horseradish peroxidase-labeled antirabbit before detection by Amersham ECL Western Blotting Detection Reagent (GE Healthcare Bio-Sciences Corporation). Immunoreactive signals were quantified by densitometry using Alpha Innotech software version 3.4.0.0 (Alpha Innotech Corporation, Santa Clara, CA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) immunoreactivity was used for normalization between samples.

Determination of ROS
--------------------

The ROS levels were determined following the addition of 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA), using the OxiSelect™ kit (Cell Bio Labs), as outlined by the manufacturer. This assay employs the cell-permeable fluorogenic probe 2,7-dichlorodihydrofuorescein diacetate (DCFH-DA) that is deacetylated by cellular esterases before undergoing ROS-dependent oxidation to the highly fluorescent 2′,7′-dichlorodihydrofluorescein (DCF).[@b18-ijn-9-1379]

Evaluation of mitochondrial membrane potential
----------------------------------------------

The extent of mitochondrial membrane damage was determined by measuring mitochondrial membrane potential (ΔΨm), using the JC 1 dye (Cell Technology), as detailed previously.[@b18-ijn-9-1379]

DNA damage assessment with comet assay
--------------------------------------

DNA damage was determined quantitatively in the control and Y~2~O~3~ NP-treated cells (1 × 10^5^ cells/mL) using the CometAssay™ kit (Trevigen, Inc.) as outlined by the manufacturer. A total of 100 cells were scored for each Y~2~O~3~ NP concentration in duplicate on three different experiments. Images were analyzed using the Perceptive Comet IV assay software version 4.3 Lite, analysis system (Perceptive Instruments Ltd Bury St Edmunds, Suffolk, UK). DNA damage was evaluated by tail moment, tail length, and tail intensity.[@b19-ijn-9-1379]

Cytokinesis-blocked micronucleus assay
--------------------------------------

Exponentially growing cells were exposed for one cell cycle (34 hours) to Mitomycin C (0.5 or 1 μg/mL) (Sigma-Aldrich) at five different concentrations of Y~2~O~3~ NPs. After washing with PBS, cells were incubated in fresh medium containing serum (5% FBS) and 3 μg/mL cytochalasin B (Sigma-Aldrich) for an additional cell cycle (34 hours). After washing, cells were trypsinized, collected by centrifugation, and incubated with 0.4% KCl for 10 minutes at 22°C--23°C. Cells were then fixed in a 1:3 solution of acetic acid and ethanol before suspension in methanol containing 1% acetic acid. Cells were air-dried on clean glass slides overnight and then stained with acridine orange, (Sigma-Aldrich) (50 μg/mL) to differentially stain the nucleus and cytoplasm before determining the number of binucleated cells containing micronuclei per 2,000 binucleated cells.[@b20-ijn-9-1379],[@b21-ijn-9-1379]

Statistical analysis
--------------------

Data are presented as mean±standard error of the mean (SEM). Dependent variables were analyzed by one-way analysis of variance using SigmaStat®, version 3.5, (Systat Software Inc., San Jose, CA, USA). A value of *P*\<0.05 was considered significant.

Results
=======

Nanoparticle characterization
-----------------------------

The average size of individual particles as estimated from atomic force microscopy width measurements was 38.6±2.0 nm ([Figure 1A](#f1-ijn-9-1379){ref-type="fig"}). The transmission electron microscopy images demonstrated that the Y~2~O~3~ NPs were largely spherical/round in shape with a primary particle diameter of 41.6±4.0 nm ([Figure 1B](#f1-ijn-9-1379){ref-type="fig"}). The mean hydrodynamic diameter of the Y~2~O~3~ NPs as measured by dynamic light scattering was 123±25 nm ([Figure 1C](#f1-ijn-9-1379){ref-type="fig"}). Confirming the purity of the Y~2~O~3~ NP preparations, the XRD spectral analysis exhibited well-defined peaks which were located at 2θ =29.1, 33.9, 48.5, and 57.6. ([Figure 1D](#f1-ijn-9-1379){ref-type="fig"}).

Y~2~O~3~ NPs exposure increases cellular ROS levels
---------------------------------------------------

The HEK293 cells were grown in the absence or presence of Y~2~O~3~ NPs, and ROS levels were quantified by measuring the enzymatic cleavage of DCFH-DA to DCF Compared to that observed in the control cells, we found an increase in fluorescence intensity in cells treated with Y~2~O~3~ NPs concentrations ≥25 μg/mL at 24 hours ([Figure 2A](#f2-ijn-9-1379){ref-type="fig"} and [2B](#f2-ijn-9-1379){ref-type="fig"}). Compared to untreated controls, paraquat increased cellular ROS levels at 24 hours and at 48 hours. The incubation of the Y~2~O~3~ NPs exposed cells with N-acetylcysteine (NAC) significantly reduced cellular ROS levels compared to that observed with exposure to Y~2~O~3~ NPs alone ([Figure 2A](#f2-ijn-9-1379){ref-type="fig"} and [2B](#f2-ijn-9-1379){ref-type="fig"}).

Cytotoxicity of Y~2~O~3~ NPs
----------------------------

The cytotoxicity of the Y~2~O~3~ NPs in the HEK cells was evaluated by IC~50~ determination, MTT assay measurement, measurement of LDH leakage, and an analysis of cellular morphology. [Figure 3A](#f3-ijn-9-1379){ref-type="fig"} shows the data of the MTT assay to determine the cytotoxicity dose (IC~50~ of Y~2~O~3~ NPs). The IC~50~ value for the Y~2~O~3~ NPs was found to be 108 μg/mL. Based on this IC~50~ value, the decision was made to vary the concentration of Y~2~O~3~ NPs from 0.25 to 50 μg/mL for further cytotoxicity studies. Compared to that observed in the control cells, the exposure to Y~2~O~3~ NPs was associated with cell clustering, cell rounding, reductions in cell size, and cell detachment from the substratum ([Figure 3B](#f3-ijn-9-1379){ref-type="fig"}). We repeated the MTT assay using similar time points and concentrations to those used to assess morphological change. The inhibition of cell survival by Y~2~O~3~ NPs was time and concentration dependent ([Figure 3C](#f3-ijn-9-1379){ref-type="fig"}). At 10 hours, only higher concentrations ≥6.125 μg decreased cell survival significantly (*P*\<0.05); whereas, at 24 hours and at 48 hours of exposure, there were significant differences at all concentrations examined. We also found that cotreatment with NAC appeared to provide a protective effect against Y~2~O~3~ NPs at 24 hours and at 48 hours. As shown in [Figure 3D](#f3-ijn-9-1379){ref-type="fig"}, LDH leakage due to Y~2~O~3~ NPs was time and concentration dependent. Compared to untreated controls, paraquat showed significant changes in the MTT assay but not LDH leakage at each time point. Similar to our MTT analysis, we also found that a cotreatment with NAC appeared to provide a protective effect against Y~2~O~3~ NPs at 48 hours (*P*\<0.05).

Exposure to Y~2~O~3~ NPs causes cell death by apoptosis and necrosis
--------------------------------------------------------------------

To investigate whether Y~2~O~3~ NPs induced apoptosis- or necrosis-mediated cell death, we used annexin V and PI double staining to detect cell membrane changes. [Figure 4A](#f4-ijn-9-1379){ref-type="fig"} shows representative flow cytograms of cells exposed for 48 hours. Concentrations of Y~2~O~3~ NPs ≥25 μg/mL revealed both early and late stages of apoptosis. Compared to untreated controls, exposure to paraquat increased early apoptosis at 24 hours and at 48 hours. Conversely, the addition of NAC (50 or 100 μM) during the Y~2~O~3~ NPs (50 μg/mL) exposure was associated with a decrease in the number of late apoptotic and necrotic cells ([Figure 4D](#f4-ijn-9-1379){ref-type="fig"}). This indicates that the NAC protects cells from both the apoptotic- and necrotic-mediated cell death induced by exposure to the Y~2~O~3~ NPs.

Compared to the control cells, Y~2~O~3~ NPs exposure decreased Bcl-2 levels by 0.67±0.06 fold (0.25 μg/mL), 0.56±0.06 fold (12.25 μg/mL), and 0.044 fold (50 μg/mL), while the paraquat treatment decreased Bcl-2 levels by 0.4±0.08 fold (100 μM/mL) ([Figure 5A](#f5-ijn-9-1379){ref-type="fig"}). Consistent with these changes in Bcl-2, the Y~2~O~3~ NPs exposure was associated with an increase in the amount of caspase-3 and cleaved caspase-3 (19 kDa) ([Figure 5B](#f5-ijn-9-1379){ref-type="fig"}).

Exposure to Y~2~O~3~ NPs causes changes in ΔΨm
----------------------------------------------

[Figure 6A](#f6-ijn-9-1379){ref-type="fig"} shows ΔΨm in control cells and cells incubated with Y~2~O~3~ NPs at various concentrations and time of exposure. We observed significant changes in ΔΨm in cells exposed to Y~2~O~3~ NPs at all three time points when the concentrations of Y~2~O~3~ NPs ranged between 6.125 to 50 μg/mL. Compared to untreated controls, the inclusion of paraquat decreased ΔΨm intensity at 24 and at 48 hours. Consistent with our MTT and LDH assays, the degree of Y~2~O~3~ NP-induced ΔΨm damage was significantly reduced at 24 hours of exposure when cells were coincubated with NAC (50 or 100 μM) ([Figure 6A](#f6-ijn-9-1379){ref-type="fig"}).

Y~2~O~3~ NPs exposure associated with DNA damage and chromosomal instability
----------------------------------------------------------------------------

Compared to control cells, the Y~2~O~3~ NP-treated cells exhibited a breakdown in nuclear morphology ([Figure 7A](#f7-ijn-9-1379){ref-type="fig"} \[b--d\]). The degree of DNA damage appeared to increase with increasing concentration of exposure as assessed by the measurement of tail length (μm), tail movement (in arbitrary units), and tail intensity (%) ([Figure 7C](#f7-ijn-9-1379){ref-type="fig"} and [D](#f7-ijn-9-1379){ref-type="fig"}; *P*\<0.05). Compared to that observed in the untreated controls, paraquat exposure increased DNA damage at 24 and 48 hours. Coincubation of the cells with 50 μM and 100 μM of the NAC that was contributed appeared to decrease the DNA damage with Y~2~O~3~ NPs exposure at 24 and 48 hours ([Figure 7C](#f7-ijn-9-1379){ref-type="fig"} and [7D](#f7-ijn-9-1379){ref-type="fig"}).

The micronucleus assay results are presented as the frequency of micronucleation per 2,000 binucleated cells ([Figure 8A](#f8-ijn-9-1379){ref-type="fig"}). Compared with the control cells, micro nucleus frequency (MNF) formation was increased in the presence of 6.125 and 12.25 μg/mL Y~2~O~3~ NPs.

Discussion
==========

It is well recognized that the toxicity of manufactured nanoparticles is heavily influenced by particle properties, such as mass, surface area, surface chemistry, state of aggregation or agglomeration, structure, size, and shape.[@b22-ijn-9-1379],[@b23-ijn-9-1379] It is thought that the particle size, shape, and chemical composition play major roles in determining the toxicity of nanoparticles.[@b24-ijn-9-1379] Our atomic force microscopy and transmission electron microscopy analysis indicated that the Y~2~O~3~ NPs appeared to be round in shape with an average size of 38.6±2.0 nm and 41.6±4.0 nm, respectively ([Figure 1A](#f1-ijn-9-1379){ref-type="fig"} and [1B](#f1-ijn-9-1379){ref-type="fig"}).

Similarly, using XRD and a comparison with known standard Y~2~O~3~ spectra, we confirmed the purity of our Y~2~O~3~ NPs ([Figure 1D](#f1-ijn-9-1379){ref-type="fig"}). After confirming the physical and chemical composition of the Y~2~O~3~ NPs, we next examined if the determined exposure to Y~2~O~3~ NPs is associated with an increased cellular ROS, as suggested by previous work using human aortic endothelial cells[@b25-ijn-9-1379] and cell-free assays.[@b10-ijn-9-1379] Consistent with these data, we also found that the Y~2~O~3~ NPs exposure also causes an increased ROS production in the HEK293 cells ([Figure 2](#f2-ijn-9-1379){ref-type="fig"}).

To confirm this finding, we next investigated the effects of cotreating the cells with Y~2~O~3~ NPs and NAC. The NAC is a known antioxidant that has been found to scavenge ROS in a variety of different cell types in vivo and in vitro.[@b26-ijn-9-1379] As expected, we found that the cotreatment of the HEK293 cells with NAC significantly reduced the DCF-associated cellular fluorescence. The mechanism by which the Y~2~O~3~ NPs might increase cellular ROS levels is not yet understood, but it may result from exchange interactions between the unpaired electrons of free radicals and the conduction band electrons of the nanoparticles, similar to that seen with single-wall carbon nanotubes, semiconductor quantum dots, TiO~2~ nanoparticles, and cerium oxide nanoparticles.[@b27-ijn-9-1379]--[@b30-ijn-9-1379]

To examine the potential threshold for cellular toxicity, we next determined the cytotoxic dose 50 (IC~50~) by the MTT assay. Our IC~50~ value of 108 μg/mL was similar to that observed by Lanone et al, who also employed Y~2~O~3~ NPs that were spherical/round in shape.[@b31-ijn-9-1379] Once the IC~50~ was determined, we next repeated the MTT assays using a variety of different conditions (0.25--50 μg/mL) at 10 hours, 24 hours, and 48 hours to determine the relationship between the exposure level and cell survival. Similar to Andelman et al[@b10-ijn-9-1379], who treated the human foreskin fibroblast cells with platelet-shaped Y~2~O~3~ NPs (25--500 μg/mL), we found that exposure to the Y~2~O~3~ NPs was associated with increased cell death, as determined as the release of LDH into the media after 24 hours and after 48 hours.

To confirm these findings and to compare the potential toxicity of the Y~2~O~3~ NPs to a known toxicant, we performed parallel experiments using paraquat as a potential mediator of cell toxicity. Paraquat (*N*,*N*′-dimethyl-4,4′-bipyridinium dichloride) is a widely used herbicide that is toxic to kidney cells and functions to increase ROS levels in humans and animals through the inhibition of mitochondrial function.[@b32-ijn-9-1379]--[@b35-ijn-9-1379] Like that observed with Y~2~O~3~ NPs, we found that the paraquat exposure induced a similar MTT response ([Figure 3C](#f3-ijn-9-1379){ref-type="fig"}). The mechanism of the paraquat and the Y~2~O~3~ NP cytotoxicity are similar but is not currently clear and will require further in-depth experimentation.

To investigate whether the increased cell death seen with the Y~2~O~3~ NPs exposure was due to increases in cellular ROS, additional experiments were performed where we incubated the HEK293 cells in the presence of Y~2~O~3~ NPs and NAC. Our data indicated that the inclusion of NAC attenuated the extent of cell death seen with exposure to Y~2~O~3~ NPs ([Figure 3](#f3-ijn-9-1379){ref-type="fig"}), suggesting that the elevations in ROS may play a role, at least in part, in causing cellular cytoxicity.

Recent reports have suggested that exposure to TiO~2~ and ZnO nanoparticles can cause apoptosis in cultured mouse epidermal JB6[@b36-ijn-9-1379] and liver hepato cellular carcinoma cell line (HepG2) cells.[@b37-ijn-9-1379],[@b38-ijn-9-1379] To investigate whether the incubation of HEK293 cells with Y~2~O~3~ NPs was associated with cell apoptosis, we performed flow cytometry. Consistent with our MTT and LDH assays, we found that incubation with Y~2~O~3~ NPs was associated with the induction of cell apoptosis (at 24 hours) and necrosis (at 48 hours; [Figure 4A](#f4-ijn-9-1379){ref-type="fig"}--[4D](#f4-ijn-9-1379){ref-type="fig"}). Similar to our findings with the MTT assay, we also found that the coadministration of NAC to the cell media was associated with increased cell survival ([Figure 3C](#f3-ijn-9-1379){ref-type="fig"}). To confirm these data biochemically, we next examined how the incubation with Y~2~O~3~ NPs affected the ratio of Bcl-2 to Bax expression and caspase-3 fragmentation, given the role of these proteins in controlling the initiation and progression of the cellular apoptosis.[@b35-ijn-9-1379] As expected from our flow cytometry data, we found that the incubation with the Y~2~O~3~ NPs was associated with an increase in the ratio of Bax to Bcl-2 protein and caspase-3 fragmentation ([Figure 5A](#f5-ijn-9-1379){ref-type="fig"} and [5B](#f5-ijn-9-1379){ref-type="fig"}). Interestingly, we failed to observe any elevations in the caspase-3 fragmentation when the cells were incubated with 50 μg/mL of Y~2~O~3~ NPs. The reasons for this finding are not entirely clear, but they are consistent with the possibility that the high concentrations of Y~2~O~3~ NPs cause cellular necrosis rather than cell apoptosis. Whether different oxide nanoparticles induce apoptosis using similar or different mechanism(s) is currently unclear.

It is thought that the mitochondria are major sites of ROS production in cells. In addition, it is well-known that the production of ROS usually precedes or accompanies the loss of ΔΨm.[@b39-ijn-9-1379] In addition to known toxicants, previous work has demonstrated that the exposure to the ZnO nanoparticles (14--20 μg/mL) causes ΔΨm damage and the induction of apoptosis in the HepG2 cells.[@b36-ijn-9-1379] Consistent with these data, we observed that the Y~2~O~3~ NPs exposure in the HEK293 cells was associated with elevations in mitochondria membrane potential ([Figure 6](#f6-ijn-9-1379){ref-type="fig"}). Taken together, these data suggest that mitochondrial dysregulation may be involved in the increased ROS production seen with Y~2~O~3~ NPs-induced cytotoxicity. To extend these findings, we next examined the Y~2~O~3~ NP-treated cells for the presence of DNA damage using the comet assay, which can be used to determine the existence of DNA-strand breaks. As expected from our cytometry analysis, we found that the exposure to Y~2~O~3~ NPs (12.25--50 μg/mL) was associated with DNA damage at 24 and 48 hours ([Figure 7](#f7-ijn-9-1379){ref-type="fig"}). Moreover, we also observed that the coincubation with NAC was protective. These data suggest that the oxidative stress likely functions as a mediator of the Y~2~O~3~ NPs-induced DNA damage. To examine if exposure to the Y~2~O~3~ NPs is associated with chromosomal damage, we next performed the cytokinesis-blocked micronucleus assay.[@b40-ijn-9-1379] Similar to previous work following the exposure of HepG2 and human bronchial epithelial cells to silver NPs,[@b41-ijn-9-1379] we found that the micronuclei formation was increased, following the cellular incubation with Y~2~O~3~ NPs (6.125 or 12.25 ug/mL).

Consistent with our findings with caspase-3, we failed to find any evidence of chromosomal damage at the higher concentrations of Y~2~O~3~ NPs treatment (25 and 50 μg/mL), which was likely due to the presence of the elevated levels of apoptotic- and necrosis-mediated cell death. To our knowledge, this is the first study to suggest quantitatively that the Y~2~O~3~ NPs treatment can cause DNA damage and chromosomal aberrations. The mechanism(s) underlying this increase in DNA damage is not clear and beyond the scope of this study. Nonetheless, it is thought that the elevations in the cellular ROS can result in the mutagenic structures, such as the 8-hydroxyadenine and the 8-hydroxyguanine, which can induce instability of repetitive sequences.[@b42-ijn-9-1379]

Conclusion
==========

A comprehensive evaluation of the Y~2~O~3~ NP cytotoxicity was performed using multiple methods. Exposure to the Y~2~O~3~ NPs-induced dose- and time-dependent cytotoxicity that was associated with diminished cell survivability, cellular necrosis, and an increase in cellular apoptosis. Cellular death appeared to be induced at least in part, by changes in the ΔΨm and elevations in the cellular ROS levels. The formation of the DNA-strand breaks and micronuclei was consistent with the presence of DNA and chromosomal damage. Taken together, these data suggest that the Y~2~O~3~ NPs may be both cytotoxic and genotoxic, depending upon the magnitude of exposure. Additional studies to evaluate the effects of the Y~2~O~3~ NP exposure on other cell types and under different experimental conditions may be warranted.

Supplementary materials
=======================

Methods
-------

### Cell culture and toxicity studies

Briefly, cells were propagated to 80% confluence in 24-well plates. The culture medium was replaced with the fresh medium, containing different doses of Y~2~O~3~ NPs (0--1,200 μg/mL) and incubated for 24 hours. The MTT reagent (50 μL) was dissolved in the culture media without serum, and the plates were incubated for 4 hours at 30°C in the dark. After removal of the surpernatant and the addition of dimethyl sulfoxided (500 μL), 150 μL of fluid from each well was transferred into a 96-well microplate. The optical density was measured at 580 nm with a microplate reader, model ELx808 (BioTek Instrument, Inc., Winooski, VT, USA). The percentage of surviving cells was determined in triplicate in three different independent experiments using 6 wells per concentration. Nonlinear regression analysis using GraphPad Prism® software (GraphPad Software, Inc., La Jolla, CA, USA) was used to determine the IC~50~ values.

### Determination of ROS

Briefly, the HEK cells were grown in 24-well plates. After the treatment period, the cells were washed with cold PBS and incubated in serum-free medium with 100 μL of 1× DCFH-DA reagent and incubated at 37°C for 1 hour. Following this incubation period, cells were washed twice with Dulbecco's Phosphate-Buffered Saline, and the assay was terminated by adding 100 μL of the 2× cell lysis buffer. The fluorescence of each cell suspension was measured with a fluorometric plate reader (SpectraMax® Gemini EM™ Microplate Reader, Molecular Devices, Sunnyvale, CA, USA) at 480 nm/530 nm. Observation of the dye uptake was determined with fluorescent microscopy using a EVOS® FL Cell Imaging System (Thermo Fisher Scientific, Pittsburgh, PA, USA)

### Evaluation of ΔΨm

The experimentally treated cells were washed with cold PBS, removed with trypsin, and centrifuged at 400× g for 10 minutes. The resulting pellets were then resuspended in PBS, and the cell density was adjusted to 1 × 10^5^ cells/mL. Aliquots (200 μL each) were then centrifuged at 400× g for 5 minutes, and the resulting cell pellets were assayed for mitochondrial membrane damage. In the absence of mitochondrial damage, the JC-1 dye accumulates in the organelle and fluoresces red. Conversely, an inability of the mitochondria to concentrate the JC-1 dye results in the accumulation of the dye in the cytoplasm and a green fluorescence. Overall fluorescence was measured with a fluorometric plate reader (SpectraMax® Gemini EM™ Microplate Reader, Molecular Devices) at 535 nm and 600 nm for green and red fluorescence, respectively. The observation of the dye uptake by the mitochondria was determined following imaging under fluorescence (EVOS fl model, Thermo Fisher Scientific).

### DNA damage by comet assay

The cells were combined with molten, low-melting agarose at 37°C at a ratio of 1:10 volume/volume, and 75 μL was placed on a Comet slide(Trevigen Inc.). Slides were then incubated at 4°C for 30 minutes before being immersed in prechilled lysis solution on ice for 1 hour. The excess buffer from the slides was removed, and the slides were immersed in an alkaline solution (49.75 mL of 0.3 M NaOH and 250 μL of 200 mM ethylenediaminetetraacetic acid (EDTA), pH \> 13) for 1 hour. The slides were washed twice for 5 minutes with 1× Tris-borate-EDTA electrophoresis buffer (89 mM Tris base, 89 mM boric acid, and 2 mM EDTA) and electrophoresed using 1× Tris-borate-ethylenediaminetetraacetic acid buffer in a horizontal gel apparatus at 1 V/cm (22 V) for 10 minutes. Slides were dehydrated using 70% ethanol for 5 minutes and then air-dried overnight before staining with SYBR® Green (Life Technologies, Carlsbad CA, USA). The slides were examined at 200× magnification using a fluorescence microscope (BX51, Olympus) connected to the Leica HD digital microscope camera Model T370B (Leica, 1700 Leider Lane, Buffalo Grove, IL, USA).
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![The Y~2~O~3~ NPs size, shape and its composition were measured by AFM, TEM, DLS and XRD analysis.\
**Notes:** (**A**) Typical AFM micrographs of Y~2~O~3~ NPs. (**B**) Typical **T**EM photomicrograph of agglomerates and single (red arrow)Y~2~O~3~ NPs. (**C**) Analysis of dynamic light scattering of Y~2~O~3~ NPs. Left y axis is cumulative % (q %) of particles (blue line). Right axis is histogram (pink bars) of particle sizes. q (%) means cumulative percent (%) of particle diameter.\
**Abbreviations:** AFM, atomic force microscopy; Y~2~O~3~, yttrium oxide; NPs, nanoparticles; TEM, transmission electron microscopy; XRD, X-ray diffraction; θ, theta; DLS, dynamic light scattering.](ijn-9-1379Fig1){#f1-ijn-9-1379}

![Cellular ROS levels in response to incubation with Y~2~O~3~ NPS\
**Notes:** (**A**) HEK293 cells were treated as indicated for 10 hours, 24 hours, and 48 hours. Cellular ROS was evaluated as described in the "Materials and methods" section. All experiments were performed in triplicate. Asterisks indicate significant difference from control (\**P*\<0.05); ^‡^significant difference from Y~2~O~3~ oxide treatment (^‡^*P*\<0.05). (**B**) Representative images of DCF fluorescence. Images were acquired by fluorescence microscopic (20×).\
**Abbreviations:** ROS, reactive oxygen species; HEK293, human embryonic kidney cells; Y~2~O~3~, yttrium oxide; NPs, nanoparticles; DCFH-DA, 2, 7-dichlorodihydrofluorescein diacetate; para, paraquat; NAC, N-acetylcysteine; Y~2~O~3~, yttrium oxide; SEM, standard error of the mean.](ijn-9-1379Fig2){#f2-ijn-9-1379}

![Cytotoxicity of Y~2~O~3~ NPs to HEK293 cell line.\
**Notes:** (**A**) Dose-dependent effects of Y~2~O~3~ NPs (0--1000 μg/mL) for 24 hours to determine the acute cytotoxicity dose (IC~50~ of Y~2~O~3~ NPs). (**B**) Morphology changes/alteration of HEK293 cells under microscope after exposures to Y~2~O~3~ NPs. (**C**) MTT assay to show cell survivability respect to dose and time-dependent effect. (**D**) Data of LDH leakage assay to show the cell membrane damage. All values are represented as percentage of (n=3) ± SEM. Asterisks indicate significant difference from control (\**P*\<0.05); significant difference from Y~2~O~3~ treatment is indicated (^‡^*P*\<0.05).\
**Abbreviations:** Y~2~O~3~, yttrium oxide; NPs, nanoparticles; HEK293, human embryonic kidney cells; IC~50~, inhibitory concentration 50; MTT, 3-\[4,5-dimethylthiazol-2-yl\]-2,5 diphenyl tetrazolium bromide; LDH, lactate dehydrogenase; SEM.](ijn-9-1379Fig3){#f3-ijn-9-1379}

![The Y~2~O~3~ NPs induced cell death (apoptosis and necrosis) was measured by flow cytometry using annexin V/FITC and PI staining.\
**Notes:** (**A**) Representative cytogram of HEK293 cell treated with Y~2~O~3~ NPs for 48 hours. Apoptotic and necrotic cell death was assessed by measuring the exposure of phosphatidylserine residues on the cell surface as described in the "Materials and methods" section (double staining with annexin V/FITC and PI). The lower left quadrant includes the viable cells, which are negative for the annexin V/FITC binding (annexin V−) and exclude PI (PI−). The lower right quadrant includes early apoptosis cells, which are positive for annexin V/FITC binding (annexin V+) but PI−. The upper right quadrant represents the late apototic cells, which are annexin V+ and show PI uptake (PI+). The upper left quadrant represents necrotic cells, which are annexin V−/PI+. (**B--D**) Percentage (%) of early apoptotic, late apoptotic, and necrosis cells. All values are represented as percentage of (n=3) ± SEM. Asterisks indicate significant difference from control (\**P*\<0.05); ‡significant difference from the Y~2~O~3~ treatment is indicated (‡*P*\<0.05).\
**Abbreviations:** Y~2~O~3~, yttrium oxide; NPs, nanoparticles; HEK293, human embryonic kidney cells; FITC, fluorescein isothiocyanate; PI, propidium iodide.](ijn-9-1379Fig4){#f4-ijn-9-1379}

![Expression of apoptosis-associated regulatory proteins in HEK293 cultures.\
**Notes:** HEK293 cells were treated with Y~2~O~3~ NPs (0--50 μg/mL) for 48 hours and the expression levels of apoptotic-associated proteins were detected in the whole cell lysate as described in the "Materials and methods" Values are presented as (n=3) ± SEM. Asterisks indicate significant difference from control (\**P*\<0.050).\
**Abbreviations:** Y~2~O~3~, yttrium oxide; NPs, nanoparticles; HEK293, human embryonic kidney cells; IC~50~, inhibitory concentration 50; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase.](ijn-9-1379Fig5){#f5-ijn-9-1379}

![Δψm damage was evaluated with HEK293 cell line using the fluorescent dye JC-1.\
**Notes:** (**A**) cells were treated with Y~2~O~3~ NPs (0--50 μg/mL) for 10 hours, 24 hours, and 48 hours. the Δψm was evaluated as described in the "Materials and methods" section. All experiments were performed in triplicate. Values expressed as mean ± SEM. Asterisks indicate significant difference from control (\**P*\<0.05); significant difference from Y~2~O~3~ treatment is indicated (^‡^*P*\<0.05). (**B**) Representative image of JC-1 staining.\
**Abbreviations:** para, paraquat; NAC, N-acetylcysteine; Y~2~O~3~, yttrium oxide; NPs, nanoparticles; Δψm, mitochondria membrane potential.](ijn-9-1379Fig6){#f6-ijn-9-1379}

![Typical fluorescence microscopic image of comets after alkaline gel electrophoresis.\
**Notes:** Cells were exposed to Y~2~O~3~ NPs. The comet assay was performed as described in "Materials and methods". (**A**) (a) Control cell. (b--d) Cells treated with different concentration of Y~2~O~3~ NPs. (**B--D**) Y~2~O~3~ NPs-induced DNA damage was characterized by the increase in tail length (μm), tail movement (arbitrary unit), and tail intensity (%). All experiments were performed in triplicate. All values were expressed as mean ± SEM. Asterisks indicate significant difference from control (\**P*\<0.05). Significant difference from Y~2~O~3~ treatment (^‡^*P*\<0.05).\
**Abbreviations:** Y~2~O~3~, yttrium oxide; NPs, nanoparticles; SEM, standard error of the mean; para, paraquat.](ijn-9-1379Fig7){#f7-ijn-9-1379}

![Cytokinesis-blocked micronucleus formation during Y~2~O~3~ NPs-induced genotoxiciy.\
**Notes:** (**A**) Percentage of micronuclei/binucleated cells in control and after Y~2~O~3~ NPs exposure (6.125 and 12.25 μg/mL). (**B**) Representative images (20×) showing control nucleus and nuclei after Y~2~O~3~ NPs exposure. Blue arrow indicates the micronucleus formed among the binucleated cells. The data represent 2,000 binucleated cells from each dose/treatment. Values expressed as mean ± SEM. Asterisks indicate significant difference from control (\**P*\<0.05).\
**Abbreviations:** Y~2~O~3~, yttrium oxide; NPs, nanoparticles; SEM, standard error of the mean.](ijn-9-1379Fig8){#f8-ijn-9-1379}
